AAAAAA
Results: 1-25/30
Authors:
Ikeuchi, T
Yokosuka, O
Kanda, T
Imazeki, F
Seta, T
Saisho, H
Citation: T. Ikeuchi et al., Roles of TT virus infection in various types of chronic hepatitis, INTERVIROLO, 44(4), 2001, pp. 219-223
Authors:
Fujiwara, K
Yokosuka, O
Fukai, K
Imazeki, F
Saisho, H
Omata, M
Citation: K. Fujiwara et al., Analysis of full-length hepatitis A virus genome in sera from patients with fulminant and self-limited acute type A hepatitis, J HEPATOL, 35(1), 2001, pp. 112-119
Authors:
Kawai, S
Yokosuka, O
Imazeki, F
Maru, Y
Saisho, H
Citation: S. Kawai et al., State of HBV DNA in HBsAg-negative, anti-HCV-positive hepatocellular carcinoma: Existence of HBV DNA possibly as nonintegrated form with analysis by Alu-HBV DNA PCR and conventional HBVPCR, J MED VIROL, 64(4), 2001, pp. 410-418
Authors:
Kato, A
Miyazaki, M
Ambiru, S
Yoshitomi, H
Ito, H
Nakagawa, K
Shimizu, H
Yokosuka, O
Nakajima, N
Citation: A. Kato et al., Multidrug resistance gene (MDR-1) expression as a useful prognostic factorin patients with human hepatocellular carcinoma after surgical resection, J SURG ONC, 78(2), 2001, pp. 110-115
Authors:
Yokosuka, O
Citation: O. Yokosuka, Role of steroid priming in the treatment of chronic hepatitis B, J GASTR HEP, 15, 2000, pp. E41-E45
Authors:
Yokosuka, O
Citation: O. Yokosuka, Molecular biology of hepatitis A virus: Significance of various substitutions in the hepatitis A virus genome, J GASTR HEP, 15, 2000, pp. D91-D97
Authors:
Kanda, T
Yokosuka, O
Kawal, S
Imazeki, F
Saisho, H
Citation: T. Kanda et al., Sequence-motif analysis of 5 '-untranslated region of GB virus-C in Japanese patients, J GASTR HEP, 15(9), 2000, pp. 1048-1053
Authors:
Tagawa, M
Yamaguchi, T
Yokosuka, O
Matsutani, S
Maeda, T
Saisho, H
Citation: M. Tagawa et al., Inactivation of a hepadnavirus by electrolysed acid water, J ANTIMICRO, 46(3), 2000, pp. 363-368
Authors:
Honda, A
Hatano, M
Kohara, M
Arai, Y
Hartatik, T
Moriyama, T
Imawari, M
Koike, K
Yokosuka, O
Shimotohno, K
Tokuhisa, T
Citation: A. Honda et al., HCV-core protein accelerates recovery from the insensitivity of liver cells to Fas-mediated apoptosis induced by an injection of anti-Fas antibody inmice, J HEPATOL, 33(3), 2000, pp. 440-447
Authors:
Shiratori, Y
Perelson, AS
Weinberger, L
Imazeki, F
Yokosuka, O
Nakata, R
Ihori, M
Hirota, K
Ono, N
Kuroda, H
Motojima, T
Nishigaki, M
Omata, M
Citation: Y. Shiratori et al., Different turnover rate of hepatitis C virus clearance by different treatment regimen using interferon-beta, J HEPATOL, 33(2), 2000, pp. 313-322
Authors:
Tomita, T
Yokosuka, O
Tagawa, M
Saisho, H
Tamura, S
Fukuda, I
Omata, M
Citation: T. Tomita et al., Decrease of wild-type and precore mutant duck hepatitis B virus replication during lamivudine treatment in white Pekin ducks infected with the viruses, J HEPATOL, 32(5), 2000, pp. 850-858
Authors:
Morita, C
Sano, K
Morimatsu, S
Kiura, H
Goto, T
Kohno, T
Hong, W
Miyoshi, H
Iwasawa, A
Nakamura, Y
Tagawa, M
Yokosuka, O
Saisho, H
Maeda, T
Katsuoka, Y
Citation: C. Morita et al., Disinfection potential of electrolyzed solutions containing sodium chloride at low concentrations, J VIROL MET, 85(1-2), 2000, pp. 163-174
Authors:
Shiratori, Y
Kato, N
Yoshida, H
Nakata, R
Ihori, M
Imazeki, F
Yokosuka, O
Kawase, T
Katamoto, T
Unuma, T
Nakamura, A
Ikegami, F
Hirota, K
Omata, M
Citation: Y. Shiratori et al., Sustained viral response is rarely achieved in patients with high viral load of HCV RNA by excessive interferon therapy, DIG DIS SCI, 45(3), 2000, pp. 565-574
Authors:
Fujiwara, K
Yokosuka, O
Ehata, T
Imazeki, F
Saisho, H
Citation: K. Fujiwara et al., PCR-SSCP analysis of 5 '-nontranslated region of hepatitis A viral RNA: Comparison with clinicopathological features of hepatitis A, DIG DIS SCI, 45(12), 2000, pp. 2422-2427
Authors:
Honda, A
Yokosuka, O
Suzuki, K
Saisho, H
Citation: A. Honda et al., Detection of mutations in hepatitis B virus enhancer 2/core promoter and Xprotein regions in patients with fatal hepatitis B virus infection, J MED VIROL, 62(2), 2000, pp. 167-176
Authors:
Seta, T
Yokosuka, O
Imazeki, F
Tagawa, M
Saisho, H
Citation: T. Seta et al., Emergence of YMDD motif mutants of hepatitis B virus during lamivudine treatment of immunocompetent type B hepatitis patients, J MED VIROL, 60(1), 2000, pp. 8-16
A prospective study of interferon therapy modified by pre-treatment viral load in cirrhotic patients
Authors:
Shiratori, Y
Moriyama, M
Imazeki, F
Ohkubo, H
Tanaka, N
Arakawa, Y
Yoshida, H
Yokosuka, O
Shibuya, A
Matsuzaki, K
Hashimoto, E
Hayashi, N
Hirata, K
Ohashi, Y
Omata, M
Citation: Y. Shiratori et al., A prospective study of interferon therapy modified by pre-treatment viral load in cirrhotic patients, LIVER, 20(4), 2000, pp. 271-280
Authors:
Yokosuka, O
Ikeuchi, T
Kanda, T
Kawai, S
Imazeki, F
Saisho, H
Mazzalli, M
Alves, G
Nishimura, NF
Soares, EC
Citation: O. Yokosuka et al., The prevalence of TT virus infection in renal transplant recipients in Brazil, TRANSPLANT, 70(8), 2000, pp. 1194-1197
Authors:
Shiratori, Y
Imazeki, F
Moriyama, M
Yano, M
Arakawa, Y
Yokosuka, O
Kuroki, T
Nishiguchi, S
Sata, M
Yamada, G
Fujiyama, S
Yoshida, H
Omata, M
Citation: Y. Shiratori et al., Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy, ANN INT MED, 132(7), 2000, pp. 517-524
Authors:
Koike, K
Shimotouno, K
Okada, S
Okamoto, H
Hayashi, N
Ueda, K
Kaneko, S
Koike, K
Yokosuka, O
Chiba, T
Marusawa, H
Hino, O
Utida, T
Omata, M
Juji, T
Nojiri, N
Takada, K
Miyamura, T
Osuga, T
Ito, Y
Citation: K. Koike et al., Survey of hepatitis B virus co-infection in hepatitis C virus-infected patients suffering from chronic hepatitis and hepatocellular carcinoma in Japan, JPN J CANC, 90(11), 1999, pp. 1270-1272
Authors:
Ikeuchi, T
Okuda, K
Yokosuka, O
Kanda, T
Kobayashi, S
Murata, M
Hayashi, H
Yokozeki, K
Ohtake, Y
Kashima, T
Irie, Y
Citation: T. Ikeuchi et al., Superinfection of TT virus and hepatitis C virus among chronic haemodialysis patients, J GASTR HEP, 14(8), 1999, pp. 796-800
Authors:
Shiratori, Y
Kato, N
Yoshida, H
Imazeki, F
Okano, K
Yokosuka, O
Omata, M
Citation: Y. Shiratori et al., How soon can a virological sustained response be determined after withdrawal of interferon therapy in chronic hepatitis C?, J GASTR HEP, 14(1), 1999, pp. 79-84
Authors:
Kanda, T
Yokosuka, O
Ikeuchi, T
Seta, T
Kawai, S
Imazeki, F
Saisho, H
Citation: T. Kanda et al., The role of TT virus infection in acute viral hepatitis, HEPATOLOGY, 29(6), 1999, pp. 1905-1908
Authors:
Shiratori, Y
Yokosuka, O
Nakata, R
Ihori, M
Hirota, K
Katamoto, T
Unuma, T
Okano, K
Ikeda, Y
Hirano, M
Kawase, T
Takano, S
Matsumoto, K
Ohashi, Y
Omata, M
Citation: Y. Shiratori et al., Prospective study of interferon therapy for compensated cirrhotic patientswith chronic hepatitis C by monitoring serum hepatitis C RNA, HEPATOLOGY, 29(5), 1999, pp. 1573-1580
Authors:
Toyoda, M
Hashimoto, N
Tokita, K
Goldstein, BJ
Yokosuka, O
Kanatsuka, A
Suzuki, Y
Saito, Y
Citation: M. Toyoda et al., Increased activity and expression of MAP kinase in HCC model rats induced by 3 '-methyl-4-dimethylamino-azobenzene, J HEPATOL, 31(4), 1999, pp. 725-733